Kostis JB - Search Results

1

Does the benefit from treating to lower blood pressure targets vary with age? A systematic review and meta-analysis.

Roush GC, Zubair A, Singh K, Kostis WJ, Sica DA, Kostis JB. Roush GC, et al. Among authors: kostis jb, kostis wj. J Hypertens. 2019 Aug;37(8):1558-1566. doi: 10.1097/HJH.0000000000002079. J Hypertens. 2019. PMID: 30870246

2

The relationship of plasma renin activity to clinic and ambulatory blood pressure in elderly people with isolated systolic hypertension.

Ruddy MC, Bialy GB, Malka ES, Lacy CR, Kostis JB. Ruddy MC, et al. Among authors: kostis jb. J Hypertens Suppl. 1988 Dec;6(4):S412-5. doi: 10.1097/00004872-198812040-00129. J Hypertens Suppl. 1988. PMID: 3071579

3

Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial.

Kostis JB, Cobbe S, Johnston C, Ford I, Murphy M, Weber MA, Black HR, Plouin PF, Levy D, Mancia G, Larochelle P, Kolloch RE, Alderman M, Ruilope LM, Dahlöf B, Flack JM, Wolf R; OPERA Study Group. Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events. Kostis JB, et al. Am J Hypertens. 2002 Feb;15(2 Pt 1):193-8. doi: 10.1016/s0895-7061(01)02048-9. Am J Hypertens. 2002. PMID: 11863257 Clinical Trial.

4

Persistence of normotension after discontinuation of lifestyle intervention in the trial of TONE. Trial of Nonpharmacologic Interventions in the Elderly.

Kostis JB, Wilson AC, Shindler DM, Cosgrove NM, Lacy CR. Kostis JB, et al. Am J Hypertens. 2002 Aug;15(8):732-4. doi: 10.1016/s0895-7061(02)02942-4. Am J Hypertens. 2002. PMID: 12160197 Clinical Trial.

5

Meta-analysis, meta-regression, and meta-physics.

Kostis JB. Kostis JB. J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):64-5,75. doi: 10.1111/j.1524-6175.2003.01487.x. J Clin Hypertens (Greenwich). 2003. PMID: 12556656 Free PMC article.

6

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.

Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Kostis JB, et al. Am J Hypertens. 2004 Feb;17(2):103-11. doi: 10.1016/j.amjhyper.2003.09.014. Am J Hypertens. 2004. PMID: 14751650 Clinical Trial.

7

Beyond hypertension toward guidelines for cardiovascular risk reduction.

Volpe M, Alderman MH, Furberg CD, Jackson R, Kostis JB, Laragh JH, Psaty BM, Ruilope LM. Volpe M, et al. Among authors: kostis jb. Am J Hypertens. 2004 Nov;17(11 Pt 1):1068-74. doi: 10.1016/j.amjhyper.2004.06.017. Am J Hypertens. 2004. PMID: 15533736

8

The association of heart failure with insulin resistance and the development of type 2 diabetes.

Kostis JB, Sanders M. Kostis JB, et al. Am J Hypertens. 2005 May;18(5 Pt 1):731-7. doi: 10.1016/j.amjhyper.2004.11.038. Am J Hypertens. 2005. PMID: 15882558 Review.

9

Hypertension: definitions and guidelines.

Kostis JB, Messerli F, Giles TD. Kostis JB, et al. J Clin Hypertens (Greenwich). 2005 Sep;7(9):538-9. doi: 10.1111/j.1524-6175.2005.04813.x. J Clin Hypertens (Greenwich). 2005. PMID: 16227773 Free PMC article. No abstract available.

10

Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.

Blood Pressure Lowering Treatment Trialists' Collaboration; Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, Chalmers J, Zanchetti A, MacMahon S. Blood Pressure Lowering Treatment Trialists' Collaboration, et al. J Hypertens. 2007 May;25(5):951-8. doi: 10.1097/HJH.0b013e3280bad9b4. J Hypertens. 2007. PMID: 17414657 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page